Grimes & Company’s Cognizant CTSH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.74M | Sell |
122,379
-1,431
| -1% | -$75.4K | 0.1% | 125 |
|
|
2026
Q1 | $7.6M | Sell |
123,810
-2,012
| -2% | -$144K | 0.21% | 88 |
|
|
2025
Q4 | $10.4M | Sell |
125,822
-8,549
| -6% | -$640K | 0.25% | 74 |
|
|
2025
Q3 | $9.01M | Sell |
134,371
-14,910
| -10% | -$1.08M | 0.22% | 84 |
|
|
2025
Q2 | $11.6M | Sell |
149,281
-3,206
| -2% | -$246K | 0.32% | 70 |
|
|
2025
Q1 | $11.7M | Buy |
152,487
+1,210
| +0.8% | +$98.5K | 0.36% | 65 |
|
|
2024
Q4 | $11.6M | Buy |
151,277
+426
| +0.3% | +$33.3K | 0.34% | 71 |
|
|
2024
Q3 | $11.6M | Sell |
150,851
-7,445
| -5% | -$555K | 0.32% | 72 |
|
|
2024
Q2 | $10.8M | Buy |
158,296
+3,246
| +2% | +$220K | 0.32% | 73 |
|
|
2024
Q1 | $11.4M | Buy |
155,050
+4,661
| +3% | +$356K | 0.35% | 67 |
|
|
2023
Q4 | $11.4M | Buy |
150,389
+2,608
| +2% | +$180K | 0.38% | 61 |
|
|
2023
Q3 | $10M | Buy |
147,781
+3,602
| +2% | +$249K | 0.39% | 60 |
|
|
2023
Q2 | $9.41M | Buy |
144,179
+1,114
| +0.8% | +$69K | 0.33% | 64 |
|
|
2023
Q1 | $8.72M | Buy |
143,065
+57,581
| +67% | +$3.61M | 0.36% | 63 |
|
|
2022
Q4 | $4.89M | Sell |
85,484
-63,755
| -43% | -$3.74M | 0.21% | 90 |
|
|
2022
Q3 | $8.57M | Buy |
149,239
+14,883
| +11% | +$975K | 0.45% | 51 |
|
|
2022
Q2 | $9.07M | Buy |
134,356
+5,830
| +5% | +$446K | 0.46% | 51 |
|
|
2022
Q1 | $11.5M | Sell |
128,526
-17,689
| -12% | -$1.55M | 0.6% | 52 |
|
|
2021
Q4 | $13M | Sell |
146,215
-580
| -0.4% | -$46.6K | 0.59% | 50 |
|
|
2021
Q3 | $10.9M | Buy |
146,795
+3,983
| +3% | +$294K | 0.47% | 58 |
|
|
2021
Q2 | $9.89M | Buy |
142,812
+139,646
| +4,411% | +$10.4M | 0.43% | 63 |
|
|
2021
Q1 | $247K | Sell |
3,166
-299
| -9% | -$23.1K | 0.01% | 246 |
|
|
2020
Q4 | $284K | Hold |
3,465
| – | – | 0.01% | 226 |
|
|
2020
Q3 | $241K | Buy |
+3,465
| New | +$225K | 0.02% | 223 |
|
|
2020
Q1 | – | Sell |
-77,238
| Closed | -$4.79M | – | 238 |
|
|
2019
Q4 | $4.79M | Sell |
77,238
-26,952
| -26% | -$1.67M | 0.31% | 75 |
|
|
2019
Q3 | $6.28M | Buy |
104,190
+977
| +0.9% | +$61.8K | 0.45% | 59 |
|
|
2019
Q2 | $6.54M | Buy |
103,213
+3,687
| +4% | +$242K | 0.5% | 59 |
|
|
2019
Q1 | $7.21M | Buy |
99,526
+11,264
| +13% | +$788K | 0.57% | 52 |
|
|
2018
Q4 | $5.6M | Sell |
88,262
-9,856
| -10% | -$686K | 0.55% | 52 |
|
|
2018
Q3 | $7.57M | Buy |
98,118
+94,886
| +2,936% | +$7.42M | 0.61% | 51 |
|
|
2018
Q2 | $255K | Sell |
3,232
-48
| -1% | -$3.77K | 0.02% | 204 |
|
|
2018
Q1 | $264K | Hold |
3,280
| – | – | 0.03% | 197 |
|
|
2017
Q4 | $233K | Hold |
3,280
| – | – | 0.02% | 194 |
|
|
2017
Q3 | $238K | Hold |
3,280
| – | – | 0.03% | 178 |
|
|
2017
Q2 | $218K | Buy |
+3,280
| New | +$208K | 0.02% | 189 |
|
|
2015
Q3 | – | Sell |
-4,800
| Closed | -$293K | – | 196 |
|
|
2015
Q2 | $293K | Sell |
4,800
-92,334
| -95% | -$5.8M | 0.04% | 145 |
|
|
2015
Q1 | $6.06M | Sell |
97,134
-4,903
| -5% | -$289K | 1.46% | 23 |
|
|
2014
Q4 | $5.37M | Buy |
102,037
+75
| +0.1% | +$3.75K | 1.39% | 24 |
|
|
2014
Q3 | $4.57M | Buy |
101,962
+1,977
| +2% | +$93K | 1.19% | 31 |
|
|
2014
Q2 | $4.89M | Buy |
99,985
+3,095
| +3% | +$151K | 1.28% | 29 |
|
|
2014
Q1 | $4.9M | Buy |
96,890
+898
| +0.9% | +$44.9K | 1.38% | 28 |
|
|
2013
Q4 | $4.85M | Buy |
95,992
+46
| +0% | +$2.1K | 1.45% | 30 |
|
|
2013
Q3 | $3.94M | Buy |
95,946
+704
| +0.7% | +$26.1K | 1.33% | 35 |
|
|
2013
Q2 | $2.98M | Buy |
+95,242
| New | +$3.17M | 1.09% | 44 |
|
Other funds holding CTSH
ECSS
VF
YIH
AIM
Grimes & Company's CTSH Position: Q2 2026 in Review
Grimes & Company reduced its Cognizant (CTSH) stake by 1.2% in Q2 2026, selling an estimated $75.4K and leaving 122,379 shares worth $4.74M. The position accounts for 0.1% of the portfolio, ranked #125.
Grimes & Company first reported a position in CTSH in Q2 2013 and has held it in 44 quarters since. The position peaked at $13M in Q4 2021. 303 funds tracked by Wall St. Rank hold CTSH as of Q2 2026.
- Grimes & Company held 122,379 shares of Cognizant worth $4.74M as of Q2 2026.
- Grimes & Company sold 1,431 Cognizant shares in Q2 2026, an estimated $75.4K.
- Cognizant made up 0.1% of Grimes & Company's portfolio in Q2 2026, its #125 holding.
- Grimes & Company first reported a position in Cognizant in Q2 2013 and has held it in 44 quarters since.
- Grimes & Company's Cognizant position peaked at $13M in Q4 2021.
- 303 funds tracked by Wall St. Rank held Cognizant as of Q2 2026.
Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.